Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibudilast as an adjuvant to decompressive surgery for degenerative cervical myelopathy
2017-004856-41Phase 3Unknown
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cervical spondylomyelopathy (CSM) comparing Ibudilast plus decompressive surgery with Placebo plus decompressive surgery (2 arms). Primary endpoints: Change in modified Japanese Orthopaedic Association score and Change in Visual Analogue Scale neck pain. Status: unknown.
02
Drugs
ibudilast
03
Conditions
cervical spondylomyelopathy (CSM)
Beyond the preview
Go deeper on 2017-004856-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004856-41.